DEA Archived Press Releases

Press Releases before January 20, 2025
5 Results - Showing 1 to 5
PRESS RELEASE

Chatham County added to Atlanta/Carolinas regional High Intensity Drug Trafficking Area

SAVANNAH, Ga. - Chatham County has been added to the Atlanta-Carolinas Region High Intensity Drug Trafficking area (HIDTA) in an effort to assist in the community’s fight against drug trafficking. The designation, by the White House Office of National Drug Control Policy (ONDCP), means Chatham County will gain access to...
PRESS RELEASE

Drug Enforcement Administration welcomes HIDTA designation for Lake County, Illinois

CHICAGO – Special Agent in Charge Robert J. Bell, DEA Chicago Division, announced today that Lake County, Illinois, has been designated as a High Intensity Drug Trafficking Area (HIDTA) by the White House Office of National Drug Control Policy. The designation means Lake County will receive more resources to coordinate...
PRESS RELEASE

Bakersfield man sentenced for structuring synthetic drug proceeds

FRESNO, Calif. — Majed Bashir Akroush, aka Magic Mike, 52, of Bakersfield, was sentenced today to two years and nine months in prison for conspiring to structure over $700,000 in cash withdrawals from four different bank accounts associated with his internet businesses that sold synthetic marijuana, U.S. Attorney McGregor W...
PRESS RELEASE

U.S. Attorney Blader welcomes HIDTA designation for Eau Claire County

MADISON, Wis. – Scott. C. Blader, United States Attorney for the Western District of Wisconsin, announced today that Eau Claire County has been designated as a High Intensity Drug Trafficking Area (HIDTA) by the White House’s Office of National Drug Control Policy. The designation means Eau Claire County will receive...
PRESS RELEASE

Search of Concord warehouse leads to re-arrest of dark web vendor

OAKLAND, Calif. – Jeremy Donagal was charged in a criminal complaint filed this morning with possession of equipment for producing counterfeit drugs as well as the manufacture and sale of counterfeit drugs in a scheme to distribute counterfeit generic alprazolam (the active ingredient in the brand-name anti-anxiety medication Xanax), announced...